Anti-Hypertensives Flashcards
Dry mouth; sedation; rebound hypertension (on withdrawal)
Clonidine
Reflex tachycardia; Postural hypotension
Prazosin; Doxazosin
Sedation; postural hypotension (in volume depleted patients)
Methyldopa (Aldomet)
Therapy for hypertension during pregnancy
Methyldopa (Aldomet);
Clonidine
Used mainly in men with hypertension plus BPH
Prazosin; Doxazosin
βAdrenoceptor antagonists
Non-selective (competitively blocks β1 + β2 adrenoceptors)
(i) βBlockers (via β1) → ↓HR & ↓CO → ↓BP
(ii) β1Blockade → ↓Renin release
(iii) Blockade of β autoreceptors → ↓Sympathetic tone
Propranolol
– Dry cough
– Angioedema
– Teratogenic
Hyperkalemia
Captopril, Lisinopril, Enalapril, Ramipril
Do not enhance dilator effects of bradykinin
AT1- Receptor antagonists
β-Antagonists with Vasodilator Activities
β1 blocker + Vasodilation due to ↑Endothelial Nitric oxide (NO) release
Racemic mixture
D‐isomer → highly selective β1‐blocker;
L‐isomer → Vasodilation via ↑NO release
Nebivolol
– Hyperkalemia
– Renal impairment
– Potential teratogen
Aliskiren
(i) Reflex tachycardia;
(ii) Fluid retention;
(iii) Excessive hair growth;
(iv) Headaches/Flushing
excess cerebral/cutaneous dilation
Minoxidil; Pinacidil
↓Renin release (Kidney):
– ↓Angiotensin II/↓Arteriolar resistance
– ↓Aldosterone → ↓Na+ retention & ↓Blood volume
β blockers
a peripheral arteriolar dilator via agonist action at D1 receptors
Fenoldopam
Absorbed incompletely from the GIT;
Hardly cross the blood‐brain‐barrier
Hydrophilic β blockers
↓Ang. II & Aldosterone secretion; Dilates via ↓in Bradykinin breakdown or Increase in bradykinin secretions
Captopril, Lisinopril, Enalapril, Ramipril
Angioedema; teratogenic
Losartan, Candesartan, Valsartan, Eprosartan
AT1- Receptor antagonists
Blocks Angiotensin II actions at AT1 Receptors → ↓Vasoconstriction and ↓Aldosterone effects
Losartan, Candesartan, Valsartan, Eprosartan
Blood pressure (B.P.) =
C.O. x P.R.
bradycardia & cardiac conduction problems; impotence, peripheral vascular insufficiency, hyperglycemia, diabetes, asthma
Withdrawal s/s
nervousness, tachycardia, increase BP
Propranolol
Cardiac output (C.O) depends on
Stroke Volume (SV) & Heart Rate (HR)
Centrally‐acting sympatholytics
preferential α2 agonist stimulates
central presynaptic α2 adrenergic receptors →
↓Peripheral sympathetic drive via ↓NE release
Clonidine
Centrally‐acting sympatholytics
prodrug for methylnorepinephrine
Forms αmethylNE (an α2-agonist)
Central α2-agonism → ↓ Sympathetic tone
Methyldopa (Aldomet)
chemically‐related to thiazides but has no diuretic activity
Opens K+ channels → Hyperpolarization & prolonged dilation
- Long‐lasting arteriolar dilation → rapid fall in systemic vascular resistance and fall in BP
- Extensively bound to serum albumin & to vascular tissue; Dilates via the opening of K+ channels
Diazoxide
Contraindicated in asthma patients
Not effective in African American patients
Avoid nonselective blockers in COPD patients
Propranolol
dilates arterioles but not veins
Hydralazine
Drug accumulate in patients with
↓hepatic blood flow, e.g., elderly, liver
cirrhosis, & congestive heart failure
Lipophilic β blockers
Effectively treats hypertension, particularly in the elderly
Nifedipine; Amlodipine; Verapamil; Diltiazem